[1]
Lopo Vitorino, M. and Pavão Martins, I. 2024. Efficacy and Safety of Fremanezumab in Patients with Migraine: Real-World Evidence in a Private Neurological Center. Sinapse. 22, 2 (Apr. 2024), 56–65. DOI:https://doi.org/10.46531/sinapse/AO/220005/2022.